Rutgers Racing to Discover a Better Paxlovid
Researchers from Rutgers Health believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid – an antiviral medication that helps keep high-risk patients out of the hospital.
Their report, published in Science, shows that an alternative medication, a viral papain-like protease inhibitor, inhibits disease progression in animals, a necessary step before human drug trials.